Koninklijke Philips N.V. (0LNG.IL)

19,66 +0,20 (+1,03%) Alla chiusura: 06:06PM BST

Koninklijke Philips N.V.

Philips Center
Amstelplein 2
Amsterdam 1096 BC
Netherlands
31 20 597 7777
https://www.philips.com

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 71.519

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Roy Jakobs	Pres, CEO & Chairman of Management	1,28M	N/D	1974
Dr. Paulus A. Stoffels M.D., Ph.D.	Independent Vice Chairman of Supervisory Board & Sec.	177,27k	N/D	1962
Mr. Abhijit Bhattacharya	Exec. VP, CFO & Member of the Board of Management	1,13M	485,44k	1961
Mr. Marnix J. van Ginneken	Exec. VP, Chief ESG, Legal Officer & Member of the Board of Management	831,35k	244,75k	1973
Mr. Willem Appelo	Exec. VP & COO	N/D	N/D	1965
Mr. Leandro Mazzoni	Head of Investor Relations	N/D	N/D	N/D
Ms. Daniela Seabrook	Exec. VP & Chief HR Officer	N/D	N/D	1973
Mr. Sean Carney	Chief Design Officer	N/D	N/D	N/D
Mr. Andy Ho	Exec. VP & Chief Market Leader of Philips Greater China	N/D	N/D	1961
Jan Kimpen	Chief Medical Officer	N/D	N/D	1958

Gli importi risalgono al giorno 31 dicembre 2022 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in EUR.

Descrizione

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. It has strategic partnership agreements with TriHealth, Prisma Health, and the University Health System of San Antonio to help the health system standardize patient monitoring, drive interoperability, and lay the foundation for enterprise-wide platform; and Oulu University Hospital to deliver advanced image-guided therapy solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Governance aziendale

L'ISS Governance QualityScore di Koninklijke Philips N.V. al 1 ottobre 2023 è 3. I criteri di valutazione fondamentali sono revisione: 1; Consiglio di Amministrazione: 1; diritti degli azionisti: 5; retribuzione: 6.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.